Burden of illness among subgroups of patients with primary Sjogren's syndrome and systemic involvement

被引:15
作者
Gairy, Kerry [1 ]
Knight, Claudia [2 ]
Anthony, Papa [2 ]
Hoskin, Ben [2 ]
机构
[1] GlaxoSmithKline, Value Evidence & Outcomes, Brentford, Middx, England
[2] Adelphi Real World, Adelphi Grp, Macclesfield, Cheshire, England
关键词
primary Sjogren's syndrome; systemic autoimmune disease; real-world evidence; latent class analysis; cluster analysis; DISEASE-ACTIVITY; SYMPTOMS; FATIGUE; VALIDATION; PREDICTORS; DIAGNOSIS; PHYSICIAN; SEVERITY; INDEX;
D O I
10.1093/rheumatology/keaa508
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives. To describe how patients with primary SS (pSS) and systemic organ involvement are classified and clustered in routine practice. Methods. This multinational, cross-sectional survey of real-world quantitative data was conducted across Europe and the US. Rheumatologists who treated seven or more adult patients per month with pSS and current/past systemic manifestations undertook a survey before completing a patient record form capturing demographic, clinical and treatment information for their next six eligible patients. Patients with a completed patient record form were invited to complete a patient self-completion questionnaire capturing insights into their disease and treatment. Subgroups were defined by physicians' assessment of disease severity; clusters were derived based on key clinical characteristics using latent class analysis. Results. Rheumatologists completed 316 physician surveys and 1879 patient record forms; 888 patients completed the patient self-completion questionnaire. pSS severity reflected organ involvement and symptomatology. Latent class analysis produced five clusters distinguished by the organ systems involved and the presence of pain and fatigue symptoms at the time of the survey. A minority of patients [n = 67 (4%)] were categorized with multiple organ involvement and the highest frequency of pain and fatigue. A total of 324 patients (17%) were categorized as 'low burden'. The remaining three clusters exhibited high frequencies of articular involvement but were distinguished by the extent of other organ system involvement. Conclusion. Cluster analysis using a real-world cohort of patients with pSS and systemic organ involvement highlights the heterogeneous presentation of patients with pSS and confirms the importance of pain and fatigue as well as organ involvement when determining disease burden.
引用
收藏
页码:1871 / 1881
页数:11
相关论文
共 36 条
  • [1] Real-world physician and patient behaviour across countries: Disease-Specific Programmes - a means to understand
    Anderson, P.
    Benford, M.
    Harris, N.
    Karavali, M.
    Piercy, J.
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2008, 24 (11) : 3063 - 3072
  • [2] Immunopathogenesis of Sjogren's syndrome
    Borchers, AT
    Naguwa, SM
    Keen, CL
    Gershwin, ME
    [J]. CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY, 2003, 25 (01) : 89 - 104
  • [3] Reviewing primary Sjogren's syndrome: beyond the dryness - From pathophysiology to diagnosis and treatment
    Both, Tim
    Dalm, Virgil A. S. H.
    van Hagen, P. Martin
    van Daele, Paul L. A.
    [J]. INTERNATIONAL JOURNAL OF MEDICAL SCIENCES, 2017, 14 (03): : 191 - 200
  • [4] Estimating Indirect Costs in Primary Sjogren's Syndrome
    Bowman, Simon J.
    Pierre, Yvan St.
    Sutcliffe, Nurhan
    Isenberg, David A.
    Goldblatt, Fiona
    Price, Elizabeth
    Hamburger, John
    Richards, Andrea
    Rauz, Saaeha
    Regan, Marian
    Rigby, Shirley
    Jones, Adrian
    Mulherin, Diarmuid
    Clarke, Ann E.
    [J]. JOURNAL OF RHEUMATOLOGY, 2010, 37 (05) : 1010 - 1015
  • [5] Bowman SJ, 2003, J RHEUMATOL, V30, P1259
  • [6] Epidemiological profile and north-south gradient driving baseline systemic involvement of primary Sjogren's syndrome
    Brito-Zeron, Pilar
    Acar-Denizli, Nihan
    Ng, Wan-Fai
    Horvath, Ildiko Fanny
    Rasmussen, Astrid
    Seror, Raphaele
    Li, Xiaomei
    Baldini, Chiara
    Gottenberg, Jacques-Eric
    Danda, Debashish
    Quartuccio, Luca
    Priori, Roberta
    Hernandez-Molina, Gabriela
    Armagan, Berkan
    Kruize, Aike A.
    Kwok, Seung-Ki
    Kvarnstrom, Marika
    Praprotnik, Sonja
    Sene, Damien
    Gerli, Roberto
    Solans, Roser
    Rischmueller, Maureen
    Mandl, Thomas
    Suzuki, Yasunori
    Isenberg, David
    Valim, Valeria
    Wiland, Piotr
    Nordmark, Gunnel
    Fraile, Guadalupe
    Bootsma, Hendrika
    Nakamura, Hideki
    Giacomelli, Roberto
    Devauchelle-Pensec, Valerie
    Hofauer, Benedikt
    Bombardieri, Michele
    Trevisani, Virginia Fernandes Moca
    Hammenfors, Daniel
    Pasoto, Sandra G.
    Retamozo, Soledad
    Gheita, Tamer A.
    Atzeni, Fabiola
    Morel, Jacques
    Vollenweider, Cristina
    Zeher, Margit
    Sivils, Kathy
    Xu, Bei
    Bombardieri, Stefano
    Sandhya, Pulukool
    De Vita, Salvatore
    Minniti, Antonina
    [J]. RHEUMATOLOGY, 2020, 59 (09) : 2350 - 2359
  • [7] Direct healthcare costs and predictors of costs in patients with primary Sjogren's syndrome
    Callaghan, R.
    Prabu, A.
    Allan, R. B.
    Clarke, A. E.
    Sutcliffe, N.
    Pierre, Yvan St.
    Gordon, C.
    Bowman, S. J.
    [J]. RHEUMATOLOGY, 2007, 46 (01) : 105 - 111
  • [8] Management of primary Sjogren's syndrome: recent developments and new classification criteria
    Del Papa, Nicoletta
    Vitali, Claudio
    [J]. THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE, 2018, 10 (02) : 39 - 54
  • [9] FACIT.org. Questionnaires, 2019, QUEST FUNCT ASS CHRO
  • [10] Factors associated with severe dry eye in primary Sjogren's syndrome diagnosed patients
    Fernandez Castro, Monica
    Sanchez-Piedra, Carlos
    Luis Andreu, Jose
    Martinez Taboada, Victor
    Olive, Alejandro
    Rosas, Jose
    [J]. RHEUMATOLOGY INTERNATIONAL, 2018, 38 (06) : 1075 - 1082